Rhee, Ina P.,Kim, Jeong,Huseni, Mahrukh,Stefanich, Eric,Sukumaran, Sid,Li, Chi-Chung
申请号：
AU2016274585
公开号：
AU2016274585A1
申请日:
2016.06.07
申请国别(地区):
AU
年份:
2017
代理人:
摘要：
The invention provides methods of treating or delaying progression of cancer in an individual comprising administering to the individual an anti-human OX40 agonist antibody. In some embodiments, the antibody is administered in a dose selected from about 0.2mg, about 0.8mg, about 3.2mg, about 12mg, about 40mg, about 80mg, about 130mg, about 160mg, about 300mg, about 320mg, about 400mg, about 600mg, and about 1200mg.
